Literature DB >> 3600288

Effect of Duchenne muscular dystrophy on enzymes of energy metabolism in individual muscle fibers.

M M Chi, C S Hintz, D McKee, S Felder, N Grant, K K Kaiser, O H Lowry.   

Abstract

Individual muscle fibers from patients with Duchenne muscular dystrophy at an early stage in their disease, and from apparently normal boys of similar age, were analyzed for 13 enzymes of energy metabolism. This approach avoided the serious problems with muscle homogenate assays from increases in nonparenchymal components and permitted assessment of disease changes in different fiber types. Some enzymes of glycogenolysis (phosphorylase, phosphoglucomutase, and pyruvate kinase) were decreased in dystrophic fibers of all types. Phosphofructokinase was decreased in presumptive type II fibers. Lactate dehydrogenase was increased in type I fibers and essentially unchanged in type II. Phosphoglucoisomerase was near normal. Two enzymes of glucose metabolism not involved in glycogenolysis, hexokinase and glycogen synthase, were near normal, but a third, fructose bisphosphatase, was sharply reduced. Two enzymes of oxidative metabolism, citrate synthase, and beta-hydroxyacyl CoA dehydrogenase, were unchanged or increased. Two enzymes of high energy phosphate transfer, creatine kinase and adenylokinase, were only marginally affected. The net result is to leave the type II fibers, which normally exert the greatest force, with a severe deficit in the glycogenolytic enzyme machinery to maintain that force.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3600288     DOI: 10.1016/0026-0495(87)90113-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  19 in total

1.  Hexose transport in human myoblasts.

Authors:  O T Mesmer; T C Lo
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.

Authors:  D Gardan-Salmon; J M Dixon; S M Lonergan; J T Selsby
Journal:  Eur J Appl Physiol       Date:  2011-03-16       Impact factor: 3.078

3.  Reducing sarcolipin expression improves muscle metabolism in mdx mice.

Authors:  Rekha Balakrishnan; Satvik Mareedu; Gopal J Babu
Journal:  Am J Physiol Cell Physiol       Date:  2022-01-05       Impact factor: 4.249

4.  The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice.

Authors:  Muhammad Muddasir Qureshi; Warren C McClure; Nicole L Arevalo; Rick E Rabon; Benjamin Mohr; Swapan K Bose; Joe M McCord; Brian S Tseng
Journal:  J Diet Suppl       Date:  2010-06-01

Review 5.  Dystrophin-dependent efficiency of metabolic pathways in mouse skeletal muscles.

Authors:  A E Chinet; P C Even; A Decrouy
Journal:  Experientia       Date:  1994-06-15

6.  Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice.

Authors:  Warren C McClure; Rick E Rabon; Hirofumi Ogawa; Brian S Tseng
Journal:  Neuromuscul Disord       Date:  2007-06-27       Impact factor: 4.296

7.  Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Meredith Oltmann; Chiara Rinaldi; Kyu H Myung; James G Tidball
Journal:  Hum Mol Genet       Date:  2009-06-19       Impact factor: 6.150

8.  Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy.

Authors:  Meghna Pant; Danesh H Sopariwala; Naresh C Bal; Jeovanna Lowe; Dawn A Delfín; Jill Rafael-Fortney; Muthu Periasamy
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

9.  Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency.

Authors:  Emma Rybalka; Cara A Timpani; Matthew B Cooke; Andrew D Williams; Alan Hayes
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 10.  Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy.

Authors:  Emma Rybalka; Cara A Timpani; Christos G Stathis; Alan Hayes; Matthew B Cooke
Journal:  Nutrients       Date:  2015-11-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.